medigraphic.com
SPANISH

Revista ADM Órgano Oficial de la Asociación Dental Mexicana

ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 1

<< Back Next >>

Rev ADM 2016; 73 (1)

Oral and cutaneous manifestations of pemphigus vulgaris

González MM, Fernández VR, Rosende RÓ, Krupp S, Fernández ER
Full text How to cite this article

Language: Spanish
References: 22
Page: 28-32
PDF size: 490.37 Kb.


Key words:

Pemphigus vulgaris, bullous and vesicular lesions, mucocutaneous diseases, bullous disease, complementary examinations, diagnosis.

ABSTRACT

Pemphigus vulgaris is an autoimmune blistering disease that typically affects the mucosa and areas of friction or trauma on the skin. It is a rare form of the disease but one that can prove fatal if not treated in time. It is more common in women between the fourth and sixth decades of life. We look at the case of a 35-year-old male patient presenting bullous lesions of the mouth that were affecting his ability to carry out his daily activities. The patient sought hospital medical care as the lesions had spread to the thorax. Diagnosis was made by biopsy, which was sent to the pathological anatomy laboratory of the Faculty of Dentistry of Argentina’s National University of the Northeast (UNNE). He prescribed treatment consisted of topical and systemic corticosteroids, starting with high doses and subsequently decreasing these in the maintenance stage. The prognosis was good and by two weeks the patient’s state of oral health was returning to normal.


REFERENCES

  1. Williams DS. Pemphigus. J Insur Med. 2004; 36: 267-268.

  2. Camacho-Alonso F, López-Jornet P, Bermejo-Fenoll A. Pemphigus vulgaris. A presentation of 14 cases and review of the literature. Med Oral Patol Oral Cir Bucal. 2005; 10 (4): 282-288.

  3. Nunes RLG, Moresco VR, Marley G, da Silva BC, Pérez P M. Pénfigo vulgar. Caso clínico. Av Odontoestomatol. 2005; 21 (4): 189-193.

  4. Black M, Mignogna MD, Scully C. Number II. Pemphigus vulgaris. Oral Dis. 2005; 11 (3): 119-130.

  5. Lin MS, Swartz SJ, López A, Ding X, Fairley JA, Díaz LA. T-lymphocytes from a subset of patients with pemphigus vulgaris respond to both desmoglein 3 and desmoglein 1. J Invest Dermatol. 1997; 109: 734-737.

  6. Bianciotto C, Herreras-Cantalapiedra JM, Alvarez MA, Méndez-Díaz MC. Conjunctival blistering associated with pemphigus vulgaris: report of a case. Arch Soc Esp Oftalmol. 2005; 80 (6): 365-368.

  7. Mao X, Payne AS. Seeking approval: present and future therapies for pemphigus vulgaris. Curr Opin Investig Drugs. 2008; 9 (5): 497-504.

  8. Bascones MA, Llanes MF. Medicina bucal. Madrid: Ediciones Avances Médico-Dentales; 1991.

  9. Martel P, Joly P. Pemphigus: autoimmune diseases of keratinocyte’s adhesion molecules. Clin Dermatol. 2001; 19 (6): 662-674.

  10. Venugopal SS, Murrell DF. Diagnosis and clinical features of pemphigus vulgaris. Immunol Allergy Clin North Am. 2012; 32: 233-243.

  11. Sciubba JJ. Oral mucosal diseases in the office setting. Part II: oral lichen planus, pemphigus vulgaris, and mucosal pemphigoid. Gen Dent. 2007; 55: 464-476.

  12. Scully C, Paes De Almeida O, Porter SR, Gilkes JJ. Pemphigus vulgaris: the manifestations and long-term management of 55 patients with oral lesions. Br J Dermatol. 1999; 140: 84-89.

  13. Bascones-Martínez A, Figuero-Ruiz E, Esparzo-Gómez G. Úlceras orales. Med Clin. 2005; 125 (15): 590-597.

  14. Bermejo-Fenoll A, López-Jornet P. Diagnóstico de las enfermedades vesiculares y ampollares de la mucosa bucal: desórdenes de la cohesión intraepitelial y de la unión epitelioconectiva. Med Oral. 1996; 1: 24-43.

  15. Souza TE, Aiello BE, Díaz RE, Montenegro Ch LE. Manifestaciones bucales del pénfigo vulgar: consideraciones generales. Reporte de caso clínico. Acta Odontol Venez [Internet]. 2012; 50 (2). Disponible en: http://www.actaodontologica.com/ediciones/2012/2/art15.asp

  16. Guillen S, Khachemoune A. Pemphigus vulgaris: a short review for the practitioner. Dermatol Nurs. 2007; 19 (3): 269-272.

  17. Mutasim DF, Pelc NJ, Anhalt GJ. Drug-induced pemphigus. Dermatol Clin. 1993; 11: 463-471.

  18. Korman NJ, Eyre RW, Zone J, Stanley JR. Drug induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus. J Invest Dermatol. 1991; 96: 273-276.

  19. Fatahzadeh M. Timely recognition of pemphigus vulgaris by dental professionals. Quintessence Int. 2013; 44 (7): 521-530.

  20. Neville D, Allen B. Oral and maxillofacial pathology. 2nd ed. Philadelphia: Saunders; 2008. p. 664-667.

  21. Tirado-Sánchez A, Ponce-Olivera RM, Montes de Oca-Sánchez G, León-Dorantes G. Pénfigo vulgar. Estudio epidemiológico y análisis de posibles factores de riesgo de mortalidad. Dermatol Rev Mex. 2006; 50: 50-53.

  22. Shamim T, Varghese VI, Shameena PM, Sudha S. Pemphigus vulgaris in oral cavity: clinical analysis of 71 cases. Med Oral Patol Oral Cir Bucal. 2008; 13: 622-626.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev ADM. 2016;73